Sfoglia per AUTORE
PISANO C
Collezione ASL Asti

  

Items : 14

Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma. in Journal of clinical medicine / J Clin Med. 2024 Jan 5;13(2):307. doi: 10.3390/jcm13020307.

2024
ASL Asti
AOU San Luigi di Orbassano

Buttigliero C; Carfì FM; Tucci M; Calabrese M; Saporita I; Pisano C; Turco F; Delcuratolo MD; Di Stefano RF; Samuelly A;

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Città di Torino
AO Cuneo
ASL Asti
ASL Cuneo 2
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Maio MD; Buttigliero C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Ruatta F; Tucci M; Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; et alii...

Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.

2023
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ungaro A; Parlagreco E; Audisio A; Audisio M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Tucci M; Turco F;

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? in Research and reports in urology / Res Rep Urol. 2023 Jan 19;15:9-26. doi: 10.2147/RRU.S350793. eCollection 2023.

2023
ASL Asti

Di Stefano RF; Saporita I; Calabrese M; Cani M; Farinea G; Crespi V; De Filippis M; Poletto S; Pisano C; Di Prima L; Turco F; Tucci M; Buttigliero C;

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? in Cells / Cells. 2022 May 11;11(10):1614. doi: 10.3390/cells11101614.

2022
ASL Asti

Tucci M; Cani M; Farinea G; Crespi V; Di Prima L; Di Stefano RF; Parlagreco E; Pisano C; Delcuratolo MD; Turco F; Buttigliero C; Audisio M;

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Delcuratolo MD; Ungaro A; Buttigliero C; Di Maio M; Audisio A; Di Prima L; Turco F; Scagliotti GV; Pisano C; Tucci M;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pisano C; DI Maio M; Tucci M; Scagliotti GV; Samuelly A; DI Stefano RF; Turco F; Bungaro M; Parente A; Buttigliero C; Angusti T;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.

2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Turco F; Ungaro A; Audisio M; Scagliotti GV; Di Maio M; Delcuratolo MD; Audisio A; Ortega C; Pisano C; Buttigliero C; Di Stefano RF; Tucci M;

Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2021 Sep;24(3):812-825. doi: 10.1038/s41391-021-00336-1. Epub 2021 Fe

2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano

Di Maio M; Scagliotti GV; Gallicchio M; Vignani F; Pisano C; Bungaro M; Samuelly A; Turco F; Tucci M; Di Stefano RF; Buttigliero C;

Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.

2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Pisano C; Audisio M; Samuelly A; Bungaro M; Tucci M; Di Stefano RF; Turco F;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Buttigliero C; Di Maio M; Scagliotti GV; Di Stefano RF; Turco F; Tucci M; Pisano C;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;

Oligoprogressive Disease With SCLC Transformation in EGFR-Mutated NSCLC: How Biology Knowledge Can Change the Game Rules. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2020 Oct;15(10):e170-e172. doi: 10.1016/j.jtho.2020.06.020.

2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

Novello S; Righi L; Mantovani C; Napoli VM; Pisano C; Olmetto E; Bertaglia V; Bironzo P; Pignataro D;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24

2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Di Maio M; Tucci M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Pisano C; Di Stefano RF; Buttigliero C; Leone G;